Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database
- PMID: 22674685
- PMCID: PMC4267226
- DOI: 10.1002/pds.3290
Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database
Abstract
PURPOSE: Use of administrative or population-based databases for post-marketing pharmacoepidemiology research in patients with end-stage liver disease (ESLD) has been limited by the difficulty of accurately identifying such patients. Algorithms to identify patients with ESLD using ICD-9-CM codes have not been developed outside of the Veterans Affairs healthcare setting. METHODS: We queried electronic medical records at two tertiary care hospitals to identify patients with ICD-9-CM codes indicative of ESLD. Coding algorithms were developed to identify patients with confirmed ESLD, and these were tested to determine their positive predictive value (PPV). RESULTS: The presence of one inpatient or outpatient ICD-9-CM code for: (i) cirrhosis; (ii) chronic liver disease, and (iii) a hepatic decompensation event yielded a PPV of 85.2% (167/196; 95% CI: 79.4%-89.9%). The PPV increased to 89.3% (150/168; 95% CI: 83.6%-93.5%) when the algorithm required two or more ICD-9-CM codes for a hepatic decompensation. However, an algorithm requiring only one ICD-9-CM code for (i) cirrhosis and (ii) a hepatic decompensation event, in the absence of a chronic liver disease code, yielded a PPV of 85.7% (30/35; 95% CI: 69.7%-95.2%). CONCLUSIONS: A coding algorithm that includes at least one ICD-9-CM code for cirrhosis plus one ICD-9-CM code for a hepatic decompensation event has a high PPV for identifying patients with ESLD. The inclusion of at least two codes indicative of a hepatic decompensation event increased the PPV. This algorithm can be used in future epidemiologic studies to examine the outcomes of a variety of long-term medical therapies in patients with ESLD. Copyright © 2012 John Wiley & Sons, Ltd.
Copyright © 2012 John Wiley & Sons, Ltd.
Conflict of interest statement
The authors of this manuscript have no conflicts of interest to disclose as described by Pharmacoepidemiology and Drug Safety.
Similar articles
-
Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database.Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):103-7. doi: 10.1002/pds.3367. Epub 2012 Nov 4. Pharmacoepidemiol Drug Saf. 2013. PMID: 23124932 Free PMC article.
-
Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative data.Pharmacoepidemiol Drug Saf. 2015 Jan;24(1):107-11. doi: 10.1002/pds.3721. Epub 2014 Oct 21. Pharmacoepidemiol Drug Saf. 2015. PMID: 25335773 Free PMC article.
-
Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study.Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):689-99. doi: 10.1002/pds.2148. Epub 2011 May 27. Pharmacoepidemiol Drug Saf. 2011. PMID: 21626605 Free PMC article.
-
A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.Vaccine. 2013 Dec 30;31 Suppl 10:K41-61. doi: 10.1016/j.vaccine.2013.03.075. Vaccine. 2013. PMID: 24331074 Review.
-
A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative data.Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:265-73. doi: 10.1002/pds.2309. Pharmacoepidemiol Drug Saf. 2012. PMID: 22262616 Review.
Cited by
-
Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.Cardiovasc Ther. 2015 Aug;33(4):177-83. doi: 10.1111/1755-5922.12129. Cardiovasc Ther. 2015. PMID: 25930214 Free PMC article.
-
Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection.J Hepatol. 2014 Aug;61(2):210-8. doi: 10.1016/j.jhep.2014.04.001. Epub 2014 Apr 5. J Hepatol. 2014. PMID: 24713185 Free PMC article.
-
Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis.Dig Dis Sci. 2022 Apr;67(4):1399-1408. doi: 10.1007/s10620-021-06943-1. Epub 2021 Mar 24. Dig Dis Sci. 2022. PMID: 33761091 Free PMC article.
-
Hypoglycemia is an early, independent predictor of bacteremia and in-hospital death in patients with cirrhosis.Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e693-e699. doi: 10.1097/MEG.0000000000002218. Eur J Gastroenterol Hepatol. 2021. PMID: 34074985 Free PMC article.
-
Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease.J Palliat Med. 2020 Jan;23(1):97-106. doi: 10.1089/jpm.2019.0100. Epub 2019 Aug 9. J Palliat Med. 2020. PMID: 31397615 Free PMC article.
References
-
- Kramer JR, Davila JA, Miller ED, Richardson P, Giordano TP, El-Serag HB. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther. 2008;27(3):274–82. Epub 2007/11/13. - PubMed
-
- Lo Re V, 3rd, Lim JK, Goetz MB, Tate J, Bathulapalli H, Klein MB, et al. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf. 2011;20(7):689–99. Epub 2011/06/01. - PMC - PubMed
-
- Arvaniti V, D’Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139(4):1246–56. 56 e1–5. Epub 2010/06/19. - PubMed
-
- Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, et al. Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology. 2008;51(Suppl 1):17–26. Epub 2008/06/27. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources